Presentation is loading. Please wait.

Presentation is loading. Please wait.

Infiltrating Basal Cell Carcinoma Maysoon ALGain Dermatology Demonstrator KAAU.

Similar presentations


Presentation on theme: "Infiltrating Basal Cell Carcinoma Maysoon ALGain Dermatology Demonstrator KAAU."— Presentation transcript:

1 Infiltrating Basal Cell Carcinoma Maysoon ALGain Dermatology Demonstrator KAAU

2 Case Presentation CC: growth on right side of nose HPI: 81 yo HF who first noted growth on right side of nose “last December”, progressively growing. PMH: arthritis SH: ½ ppd smoker X 25 years ROS: denies F/C, significant weight loss FH: non-contributory

3 Physical Exam General: AAO, VSS and good VA: 20/80 OD, 20/50 OS Pupils: 3mm OU, no APD External: extensive ulcerative lesion from bridge of nose to RLL and R cheek, with almost complete destruction of RLL and nearly complete ptosis of RUL IOP, CVF, DFE normal OS, unobtainable OD

4

5

6 Differential Diagnosis Malignant melanoma Squamous cell carcinoma Basal cell carcinoma, infiltrative Infectious

7 Basics of BCC Background –Most common cutaneous malignancy (~80- 90%) –Typically slow-growing, rarely metastasizes –Sun-exposed skin, mostly face and scalp, esp nose, cheek, and periorbital regions (~80%) Frequency –900,000 Dx in US/year –estimated lifetime risk of 33-39% for men and 23-28% for women Sex –Men 2X over women

8 Basics of BCC Mortality/Morbidity –<0.1% metastasize –Very low mortality –Significant morbidity with direct invasion of adjacent tissues, especially when on face or near an eye Age –Likelihood increases with age –Rare in <40 yo Race –Most often in light-skinned, rare in dark- skinned races

9 Variants of Basal Cell Carcinoma Superficial Nodular Micronodular Infiltrating (5%) Sclerosing/ morpheaform (5%) Metatypical Infundibulocystic Nodulocystic Adenoid Clear cell Follicular Sebaceous Perineurally invasive

10 Perineural Invasion May be seen in 3% of pts with infiltrating and morpheaform types –Most often infiltrating type, which has highest rate of local recurrence Requires CT scan for full work-up Causes? inherently aggressive behavior vs inadequate early management?

11 Treatment Options Electrodessication and curettage Curettage alone Surgical excision Mohs micrographically controlled surgery Cryosurgery Ionizing radiation Surgical excision plus radiation E xenteration

12 Factors Considered in Treatment Planning Pt preference to keep eye Pt age Surgical excision-considered definitive tx “Careful frozen section controlled excision of periocular BCCs yields cure rates comparable to Mohs micrographic surgery at 5-year follow-up” –5 year recurrence of 2.2% in one study –Wong, et al. “Management of Periocular Basal Cell Carcinoma with Modified En Face Frozen Section Controlled Excision.” Ophthalmic and Plastic Reconstructive Surgery. 2002. Vol 18 (6): 430-435. Therefore, avoiding exenteration was considered a good possibility

13

14

15

16

17

18

19

20

21

22 Conclusion Basal cell carcinomas are not always as innocent as we tend to believe In formulating treatment course: –Strong pt preference and other pt factors –Current research


Download ppt "Infiltrating Basal Cell Carcinoma Maysoon ALGain Dermatology Demonstrator KAAU."

Similar presentations


Ads by Google